BeOne Medicines (ONC) Return on Invested Capital (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• On a quarterly basis, Return on Invested Capital rose 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, up 2.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for ONC reached as high as 0.0% in Q1 2026 and fell as low as 0.01% in Q1 2023.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• On a YoY basis, Return on Invested Capital climbed as much as 1 bps in 2022 and fell as far as 1 bps in 2022.
• Year by year, Return on Invested Capital stood at 0.01% in 2022, then rose by 26 bps to 0.01% in 2023, then soared by 77 bps to 0.0% in 2024, then jumped by 171 bps to 0.0% in 2025, then jumped by 167 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.